PROCEPT BioRobotics PRCT
NASDAQ PRCT
$20.38 +0.31 (+1.54%)
As of: Sep 11, 2026 · 3:59 PM EDT

PROCEPT BioRobotics (PRCT) Non-Current Assets (2020 - 2026)

PROCEPT BioRobotics' (PRCT) quarterly Non-Current Assets came in at $59.1 million in Q2 2026, up 7.42% year-over-year from $55.0 million in Q2 2025, and little changed quarter-over-quarter from $59.0 million in Q1 2026.

Analysis

PROCEPT BioRobotics (PRCT) Non-Current Assets (2020 - 2026) Analysis & Trends

PROCEPT BioRobotics (PRCT) has reported Non-Current Assets for 7 consecutive years, with $59.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Assets rose 7.42% year-over-year to $59.1 million in Q2 2026; TTM through Jun 2026 was $232.6 million, a 9.76% increase from a year earlier, with the FY2025 full-year figure at $57.7 million, up 10.6% from the prior year.
  • Non-Current Assets was $59.1 million for Q2 2026 at PROCEPT BioRobotics, roughly flat from $59.0 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $59.1 million in Q2 2026 and troughed at $12.6 million in Q2 2022.
  • A 5-year average of $46.4 million and a median of $52.5 million in 2023 frame the typical range for Non-Current Assets.
  • Across the five-year window, Non-Current Assets jumped 238.25% in 2022 and retreated 3.65% in 2024, its largest moves.
  • Over 5 years, Non-Current Assets stood at $36.7 million in 2022, then jumped by 47.54% to $54.2 million in 2023, then fell by 3.65% to $52.2 million in 2024, then rose by 10.6% to $57.7 million in 2025, then climbed by 2.36% to $59.1 million in 2026.
  • The last three Non-Current Assets figures came in at $59.1 million (Q2 2026), $59.0 million (Q1 2026), and $57.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Abbott Laboratories 178.01 Bn 172.41 Bn 7.27 Bn 84.70 Bn
2 Intuitive Surgical 131.29 Bn 126.08 Bn 1.96 Bn 11.33 Bn
3 Medtronic 116.38 Bn 107.56 Bn 6.34 Bn 68.92 Bn
4 Stryker 106.01 Bn 102.53 Bn 4.50 Bn 33.51 Bn
5 Boston Scientific 63.40 Bn 62.86 Bn 3.85 Bn 37.24 Bn
6 Edwards Lifesciences 48.89 Bn 44.64 Bn 1.35 Bn 7.05 Bn
7 Alcon 32.59 Bn 31.13 Bn 1.68 Bn 24.47 Bn
8 Dexcom 31.84 Bn 29.89 Bn 830.00 Mn 2.37 Bn
9 Steris 20.61 Bn 20.13 Bn 684.20 Mn 8.29 Bn
10 PROCEPT BioRobotics 1.17 Bn 895.36 Mn 62.38 Mn 59.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 59.07 Mn
Mar 31, 2026 59.03 Mn
Dec 31, 2025 57.70 Mn
Sep 30, 2025 56.79 Mn
Jun 30, 2025 54.99 Mn
Mar 31, 2025 53.58 Mn
Dec 31, 2024 52.18 Mn
Sep 30, 2024 51.16 Mn
Jun 30, 2024 52.46 Mn
Mar 31, 2024 53.71 Mn
Dec 31, 2023 54.15 Mn
Sep 30, 2023 52.46 Mn
Jun 30, 2023 42.43 Mn
Mar 31, 2023 38.88 Mn
Dec 31, 2022 36.70 Mn
Sep 30, 2022 35.11 Mn
Jun 30, 2022 12.59 Mn
Mar 31, 2022 12.93 Mn
Dec 31, 2021 10.85 Mn
Sep 30, 2021 11.99 Mn